Htg molecular diagnostics, inc (HTGM)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15
Operating activities
Net loss

-5,457

-4,389

-4,740

-4,797

-5,370

-2,127

-4,843

-4,102

-5,379

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-5,816

-5,673

-6,488

-6,851

-7,026

-5,699

-5,157

-6,452

-4,088

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

348

338

317

294

308

341

347

422

356

348

305

291

296

387

357

371

357

188

174

147

151

Accretion of discount on NuvoGen obligation

3

-

-

-

3

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of discount on NuvoGen obligation

-

-

-

-

-

-

-

-3

-2

47

48

49

50

50

51

52

52

-

-

-

-

Accretion of discount on NuvoGen obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

51

126

Bad debt expense, net of recoveries

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

11

50

-16

Provision for excess inventory

6

27

81

20

24

19

40

12

11

64

58

51

192

285

288

119

30

-42

62

188

21

Amortization of Growth Term Loan discount and issuance costs

-

-

-

-

-

0

0

0

62

78

94

108

122

135

148

164

102

-

-

-

-

Loss on extinguishment of Growth Term Loan

-

-

-

-

-

0

0

0

-105

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of QNAH Convertible Note issuance costs

3

3

3

3

3

3

3

3

3

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of MidCap Credit Facility discount and issuance costs

42

54

47

41

39

41

43

45

2

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

Amortization of discount on term loan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

36

Amortization of final payment premium on term loan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

24

Amortization of discount on convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

58

32

Stock-based compensation expense

415

311

316

287

241

244

257

241

1,143

204

357

417

396

351

229

152

170

181

77

70

76

Employee stock purchase plan expense

5

16

16

16

16

15

15

14

14

14

14

14

14

-

-

-

-

-

-

-

-

Amortization of operating lease right-of-use assets

151

147

135

121

72

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of incentive from landlord

-

-

-

-

-

35

35

35

35

-

-

-

-

-

-

-

-

-

-

-

-

Change in redeemable convertible preferred stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

628

-388

Amortization of convertible note financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15

Accretion of incentive from landlord

-

-

-

-

-

-

-

-

-

35

35

35

35

35

35

35

23

-

-

-

-

Accrued interest on available-for-sale securities investments

74

94

53

105

72

120

104

121

66

-

0

-11

5

-41

-5

-132

7

-

-

-

-

Loss on abandonment of assets

-49

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

55

2

-21

-49

Changes in operating assets and liabilities:
Accounts receivable

-1,961

-769

-47

631

-1,662

1,662

-120

477

-3,351

3,197

1,608

354

-181

785

-1,319

1,336

-141

19

153

-248

35

Inventory

375

105

112

2

-103

196

166

-64

-127

-63

-33

82

-63

-71

-57

-33

195

-107

-83

505

431

Prepaid expenses and other

-139

-206

-117

511

-9

-131

-156

380

21

-90

59

99

-64

-7

-232

348

-119

-171

-151

646

10

Deferred offering costs

-140

-

-

-

-

0

0

0

-2

0

0

-38

-10

-

-

-

-

-

-

-

-

Accounts payable

-410

-1,084

-244

1,653

-480

-26

533

-578

-78

-295

1,041

168

311

-357

-432

85

714

-57

-254

69

-69

Accrued liabilities

-668

86

258

192

-1,977

768

102

746

-2,065

1,749

783

-68

-388

378

-215

494

-537

502

371

-514

96

Contract liabilities

-18

35

-191

399

-55

22

-60

-156

-233

-113

190

372

-93

-

-

-

-

-

-

-

-

Operating lease liabilities

-186

-185

-175

-155

-115

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-3,930

-3,857

-4,071

-3,173

-5,592

-2,575

-3,591

-4,305

-2,701

-

-

-

-

-

-

-

-

-

-

-

-

Investing activities
Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

23

99

158

-22

14

3

-3

-9

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-4,635

-4,921

-4,381

-6,808

-6,123

-4,557

-4,489

-5,782

-4,414

Purchase of property and equipment

25

349

434

216

103

91

28

371

457

495

373

86

65

87

238

1,400

220

387

505

100

343

Sales, redemptions and maturities of available-for-sale securities

8,250

1,400

8,400

9,600

12,800

-

-

-

-

0

0

2,600

1,700

6,750

4,300

15,700

3,000

-

-

-

-

Purchase of available-for-sale securities

4,272

23,678

1,632

1,190

8,099

10,841

5,050

13,009

25,070

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by investing activities

3,952

-22,628

6,333

8,193

4,597

4,967

7,421

-10,080

-25,527

-

-

-

-

-

-

-

-

-

-

-

-

Financing activities
Net cash (used in) provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

1,634

6,662

4,061

10,918

2,779

5,239

-4,102

-32,978

-343

Proceeds from MidCap Credit Facility

-

-

-

-

-

0

0

0

7,000

-

-

-

-

-

-

-

-

-

-

-

-

MidCap Credit Facility lender fees

-

-

-

-

-

0

0

193

228

-

-

-

-

-

-

-

-

-

-

-

-

QNAH Convertible Note financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-0

75

Proceeds from Growth Term Loan

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

5,000

-

-

-

-

Payments on Growth Term Loan

-

-

-

-

-

0

0

0

1,684

1,649

1,614

1,580

1,546

-

-

-

-

-

-

-

-

Payments for extinguishment of Growth Term Loan

-

-

-

-

-

0

0

0

4,276

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from 2018 underwritten public offering, net of underwriting discounts, commissions and issuance costs of $2.6 million

-

-

-

-

-

0

0

0

37,724

-

-

-

-

-

-

-

-

-

-

-

-

Public offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

783

219

Proceeds from ATM Offering, net

2,435

-

-

-

-

0

0

0

556

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from Series A convertible preferred stock in private placement

600

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of pre-funded warrants

31

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1

7

Payments on NuvoGen obligation

287

324

347

192

463

282

294

249

185

200

200

200

200

-

-

-

-

-

-

-

-

Payments on financing leases

11

9

9

11

13

2

19

19

20

-

-

-

-

-

-

-

-

-

-

-

-

Payments on capital leases

-

-

-

-

-

-

-

-

-

25

19

-2

27

33

33

39

27

7

7

7

7

Proceeds from exercise of stock options

-

0

0

69

51

112

134

29

40

-53

55

74

35

-

-

-

-

0

28

0

4

Taxes paid for net share settlement of restricted stock awards

-7

-2

-7

-11

-9

-17

0

0

-133

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of convertible note warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-2,998

3,000

Payment of deferred offering costs

-

51

0

108

30

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) financing activities

2,760

-707

20,737

-171

-465

-121

-169

-370

38,791

-

-

-

-

-

-

-

-

-

-

-

-

Effect of exchange rates on cash

1

-34

34

-8

4

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in cash, cash equivalents and restricted cash

2,783

-27,227

23,033

4,838

-1,457

2,268

3,659

-14,756

10,562

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-1,738

242

-1,667

-1,522

4,972

13

18

48,367

2,709

Increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-4,739

1,983

-1,986

2,587

1,628

695

-8,572

9,606

-2,049

Supplemental disclosure of noncash investing and financing activities
Fixed asset purchases payable and accrued at period end

289

-13

-352

360

13

9

26

-0

3

67

337

27

44

1

-188

-816

1,030

-

-

-

-

Adoption of ASC 842, Leases

-

0

0

0

694

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred offering costs payable and accrued at period end

-

-

-

-

108

-

-

-

-

-

-

-46

76

-

-

-

-

-

-

-

-

Allocation of term loan B warrant discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

122

-

-

-

-

Accretion of preferred stock issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

10

24

Accretion of dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

367

798

Accrual of deferred offering and finance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

96

Allocation of Series E warrant convertible notes debt discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

741

Issuance of Series A convertible preferred stock in exchange for outstanding common stock

2,424

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series A convertible preferred stock in private placement, costs payable and accrued at period end

37

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock in connection with LP Purchase Agreement

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

LP Purchase Agreement, costs payable and accrued at period end

96

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Equipment purchased through capital leases

-

-

-

-

-

7

17

14

31

-

-

-

-

-

-

-

-

-

-

-

-

Debt issuance costs payable and accrued at period end

-

-

-

-

-

-

-

-

193

-

-

-

-

-

-

-

-

-

-

-

-

MidCap Term Loan fees and warrant discount

-

-

-

-

-

0

0

0

389

-

-

-

-

-

-

-

-

-

-

-

-

Stock issued for settlement of accrued bonus

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

364

-

-

-

-

Purchase of property and equipment under capital lease

-

-

-

-

-

-

-

-

-

-

-

-

-

0

17

33

176

-

-

-

-

Incentive from landlord

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

710

-

-

-

-

Retirement of treasury stock

-

-

-

-

-

-

-

-

-

0

0

0

75

-

-

-

-

-

-

-

-

Supplemental cash flow information
Cash paid for interest

164

164

173

176

172

183

166

119

83

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest

-

-

-

-

-

-

-

-

-

-

157

192

225

258

290

322

237

233

233

233

233

Cash paid for taxes

-

-

-

-

-

-

-

-

-

0

0

0

0

-

-

-

-

-

-

-

-